Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,254 | -10,902 | -29,065 | -21,244 | -13,546 |
| Depreciation Amortization | 73 | 35 | 303 | 268 | 233 |
| Accounts payable and accrued liabilities | -324 | 294 | -1,049 | -1,676 | -1,506 |
| Other Working Capital | 2,665 | -62 | -3,847 | -4,583 | -4,790 |
| Other Operating Activity | 1,690 | 168 | 1,948 | 1,884 | 1,537 |
| Operating Cash Flow | $-19,150 | $-10,467 | $-31,710 | $-25,351 | $-18,072 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28 | N/A | -137 | -115 | -97 |
| Purchase Of Investment | -40,222 | -30,264 | -9,932 | -8,981 | -8,981 |
| Sale Of Investment | 34,927 | 22,173 | 69,497 | 55,679 | 37,679 |
| Investing Cash Flow | $-5,323 | $-8,091 | $59,428 | $46,583 | $28,601 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -63 | -32 | -9,504 | -9,472 | -9,441 |
| Common Stock Issued | 252 | 4 | 142 | 106 | 103 |
| Other Financing Activity | 4,850 | 0 | 1,452 | 1,510 | -28 |
| Financing Cash Flow | $5,039 | $-28 | $-7,910 | $-7,856 | $-9,366 |
| Beginning Cash Position | 32,397 | 32,397 | 12,589 | 12,589 | 12,589 |
| End Cash Position | 12,963 | 13,811 | 32,397 | 25,965 | 13,752 |
| Net Cash Flow | $-19,434 | $-18,586 | $19,808 | $13,376 | $1,163 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,150 | -10,467 | -31,710 | -25,351 | -18,072 |
| Capital Expenditure | -28 | N/A | -137 | -115 | -97 |
| Free Cash Flow | -19,178 | -10,467 | -31,847 | -25,466 | -18,169 |